Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma.
about
Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple MyelomaBortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial.The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma.The effect of novel therapies in high-molecular-risk multiple myeloma.Evolutionary biology of high-risk multiple myeloma.Clinicopathological Characteristics of Hyperdiploidy with High-Risk Cytogenetics in Multiple Myeloma.The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma
P2860
Q28074490-C4880A6B-61A7-4611-86AC-BAB90AA9059BQ38650700-DB1F2192-0794-407D-A98C-FCC14A81D224Q47165099-6B46DEC6-67E3-411D-8227-89943F338F6DQ47375990-17EBA9CB-627F-406D-87A6-BE303F709562Q47913337-50758139-165A-40A5-BA75-88DF84688783Q50040054-09DB3839-1E86-46D9-A9BE-749FE8A41FCFQ57137807-CA4F2559-9F27-44EA-84C5-07A44294CC62
P2860
Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Baseline characteristics, chro ...... 7p in newly diagnosed myeloma.
@en
type
label
Baseline characteristics, chro ...... 7p in newly diagnosed myeloma.
@en
prefLabel
Baseline characteristics, chro ...... 7p in newly diagnosed myeloma.
@en
P2093
P2860
P356
P1476
Baseline characteristics, chro ...... 7p in newly diagnosed myeloma.
@en
P2093
Anja Seckinger
Anna Jauch
Elias K Mai
Jens Hillengass
Marc S Raab
Maximilian Merz
Thomas Hielscher
P2860
P304
P356
10.1002/AJH.24533
P577
2016-08-10T00:00:00Z